Sunday, July 12, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitors”

2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,466
Index total 30,257
Page 73 / 103

Quick answer

This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,466 results for “inhibitors” · 30,257 patents in full index Clear search

  1. US 8324155

    Quinoxaline-containing compounds as hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted
  2. US 8323671

    Prolyl hydroxylase inhibitors and methods of use

    Akebia Therapeutics, Inc. · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted
  3. US 8324385

    Diacylglycerol acyltransferase inhibitors

    Madrigal Pharmaceuticals, Inc. · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted
  4. US 8318939

    Kinase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Nov 27, 2012 · Expires Nov 22, 2032

    granted
  5. US 8318945

    Metalloprotein inhibitors

    The Regents of the University of California · Granted Nov 27, 2012 · Expires Nov 22, 2032

    granted
  6. US 8318727

    Polo-like kinase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Nov 27, 2012 · Expires Nov 22, 2032

    granted
  7. US 8318467

    Inhibitors of GSK-3 and crystal structures of GSK-3β protein and protein complexes

    Vertex Pharmaceuticals Incorporated · Granted Nov 27, 2012 · Expires Nov 22, 2032

    granted
  8. US 8314141

    Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease

    Vertex Pharmaceuticals Incorporated · Granted Nov 20, 2012 · Expires Nov 15, 2032

    granted
  9. US 8309543

    Compositions useful as inhibitors of voltage-gated sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Nov 13, 2012 · Expires Nov 8, 2032

    granted
  10. US 8309566

    Pyrimidine-2-amine compounds and their use as inhibitors of JAK kinases

    Rigel Pharmaceuticals, Inc. · Granted Nov 13, 2012 · Expires Nov 8, 2032

    granted
  11. US 8304408

    Wnt signaling inhibitors, and methods for making and using them

    The Regents of the University of California · Granted Nov 6, 2012 · Expires Nov 1, 2032

    granted
  12. US 8304414

    Pyrazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Nov 6, 2012 · Expires Nov 1, 2032

    granted
  13. US 8304385

    Macrocyclic tetrazolyl hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Nov 6, 2012 · Expires Nov 1, 2032

    granted
  14. US 8299100

    Potent and selective neuronal nitric oxide synthase inhibitors with improved membrane permeability

    Northwestern University · Granted Oct 30, 2012 · Expires Oct 25, 2032

    granted
  15. US 8299261

    1-heterocyclylsulfonyl, 3-aminomethyl, 5-(hetero-) aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors

    Takeda Pharmaceutical Company Limited · Granted Oct 30, 2012 · Expires Oct 25, 2032

    granted
  16. US 8293724

    Therapeutic applications of fatty acid amide hydrolase inhibitors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 23, 2012 · Expires Oct 18, 2032

    granted
  17. US 8293901

    MAPK/ERK kinase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Oct 23, 2012 · Expires Oct 18, 2032

    granted
  18. US 8293878

    Methods and compounds useful for the preparation of sodium glucose co-transporter 2 inhibitors

    LEXICON PHARMACEUTICALS, INC. · Granted Oct 23, 2012 · Expires Oct 18, 2032

    granted
  19. US 8288382

    Diaminothiazoles useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Oct 16, 2012 · Expires Oct 11, 2032

    granted
  20. US 8288536

    Kinase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Oct 16, 2012 · Expires Oct 11, 2032

    granted
  21. US 8288400

    Compositions useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Oct 16, 2012 · Expires Oct 11, 2032

    granted
  22. US 8288537

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Oct 16, 2012 · Expires Oct 11, 2032

    granted
  23. US 8288539

    Dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Oct 16, 2012 · Expires Oct 11, 2032

    granted
  24. US 8283309

    Bridged carbocyclic oxime hepatitis C virus serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Oct 9, 2012 · Expires Oct 4, 2032

    granted